Article info
PDFShort report
Changes in age related seroprevalence of antibody to varicella zoster virus: impact on vaccine strategy
- Correspondence to: Dr G Kudesia, Public Health Laboratory, Northern General Hospital, Herries Road, Sheffield S5 7AU, UK
Citation
Changes in age related seroprevalence of antibody to varicella zoster virus: impact on vaccine strategy
Publication history
- Accepted July 6, 2001
- First published February 1, 2002.
Online issue publication
December 27, 2022
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2002 Journal of Clinical Pathology